CompletedPhase 3NCT03676140

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

Studying Strongyloidiasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Lihir Medical Centre
Principal Investigator: Lucy John, MD
National Department of Health of Papua New Guinea
Intervention: Albendazole on Day 1(drug)
Enrollment: 20000 enrolled
Eligibility: All sexes
Timeline: 2018 – 2019

Study locations (1)

Namatanai Hospital, Namatanai, Papua New Guinea

Collaborators

London School of Hygiene and Tropical Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03676140 on ClinicalTrials.gov

← Back to all trials